Study Title: Modulation of molecular and serological biomarkers by (−)-epicatechin consumption on a murine model of metabolic dysfunction-associated steatotic liver disease
Citation: Hidalgo et al., 2025 · Biochemical and Biophysical Research Communications
What the Study Found: In a murine model of metabolic dysfunction-associated steatotic liver disease (MASLD), (−)-epicatechin consumption modulated key molecular and serological biomarkers of liver inflammation, fibrosis, and oxidative stress. The treatment improved lipid metabolism markers and reduced disease progression signals. These changes highlight the flavanol’s ability to influence liver cellular energy pathways.
What this means in real life: MASLD develops when mitochondria in liver cells struggle with fat overload and oxidative stress, leading to inflammation and scarring. This study shows that (−)-epicatechin can positively shift those biomarkers, supporting healthier mitochondrial function and slowing disease progression. Mitochondrial support is a promising approach for maintaining liver resilience under modern metabolic stress.
Contenu associé
- Curious how mitochondrial health affects liver fat and metabolic balance? → Mitochondrial Health and Fatty Liver
- Want to understand how cellular energy shapes metabolic resilience? → Mitochondrial Dysfunction and Obesity: What’s the Connection?
- Looking for ways to support mitochondrial function daily? → How to Repair and Maintain Mitochondrial Health Naturally